Barr Laboratories

Registered Principal Details

Business Or Interest:
Pharmaceuticals

Lobbying Interests:
Any and all issues pertaining to generic drugs

CEO Name:
Bruce Downey
Vice President

Contact
JH
Jake Hansen
444 North Capitol St, NW #722
Washington, DC 20001
(202) 393-6599
(202) 638-3386
dbarksdale@barrlabs.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Budget Bill Subjects

Health and Family Services: Medical Assistance
Biennial budget bill treatment of matter relating to
Health and Family Services: Medical Assistance

Notification Date
4/11/2003
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Health and Family Services: Prescription Drug Assistance
Biennial budget bill treatment of matter relating to
Health and Family Services: Prescription Drug Assistance

Notification Date
4/11/2003
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Topics Not Yet Assigned A Bill Or Rule Number

this topic relates to HIRSP & how it is funded & administered
Development, drafting or introduction of a proposal relating to
this topic relates to HIRSP & how it is funded & administered

Action Intended To Affect
Legislative Matter

Notification Date
12/12/2003
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Deals with prescription drugs and development of preferred drug list
Development, drafting or introduction of a proposal relating to
Deals with prescription drugs and development of preferred drug list

Action Intended To Affect
Legislative Matter

Notification Date
4/11/2003
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Total Lobbying Effort

  2004
January - June
2004
July - December
Total
Total Lobbying Expenditures 2004
January - June
$13,379.60
2004
July - December
$18,561.96
Total $31,941.56
Total Hours Communicating 2004
January - June
8.30
2004
July - December
2.75
Total 11.05
Total Hours Other 2004
January - June
66.85
2004
July - December
4.25
Total 71.10

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

No legislative bills/resolutions found.

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2003
January - June
2003
July - December
2004
January - June
2004
July - December
Total
2003
January - June
2003
July - December
2004
January - June
45%
2004
July - December
70%
Total 47%
2003
January - June
2003
July - December
2004
January - June
2004
July - December
Total
2003
January - June
2003
July - December
2004
January - June
45%
2004
July - December
Total 41%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2003
January - June
2003
July - December
2004
January - June
2004
July - December
Total
2003
January - June
2003
July - December
2004
January - June
10%
2004
July - December
10%
Total 10%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2003
January - June
2003
July - December
2004
January - June
2004
July - December
Total
2003
January - June
2003
July - December
2004
January - June
2004
July - December
20%
Total 2%

Filed Statements of Lobbying Activity and Expenditures